With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma||Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD||Innovation Grants||2015||California|
|Single Cell Analysis of Leukemia Initiation||Stanford University / Michael Cleary, MD||Innovation Grants||2015||California|
|Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma||Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD||Innovation Grants||2015||California|
|Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas||University of California, Davis Medical Center / Paul Knoepfler, PhD||Innovation Grants||2015||California|
|Enhanced Drug Repurposing Screen in DSRCT Enabled by New In Vitro and In Vivo Models Based on CRISPR/Cas9 Genome Engineering||Memorial Sloan-Kettering Cancer Center / Marc Ladanyi, MD & Maria Jasin, PhD||Innovation Grants||2015||New York|
|Integrative Genomic and Immunogenomic Analysis of Neuroblastoma||University of California at Santa Cruz / David Haussler, PhD||Innovation Grants||2015||California|
|Functional Analysis and Therapeutic Targeting of STAG2 Mutations in Ewing sarcoma||Georgetown University / Todd Waldman, MD, PhD||Innovation Grants||2015||District of Columbia|
|Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy||University of North Carolina / Timothy Gershon, MD, PhD||Innovation Grants||2015||North Carolina|
|Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia||Boston Children’s Hospital / Alan Cantor, MD, PhD||Innovation Grants||2015||Massachusetts|
|Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma||University of Virginia, School of Medicine / John Bushweller, PhD||Innovation Grants||2015||Virginia|